Profile of Ms Elizabeth Hardaker
Elizabeth Hardaker is a Senior Director at AstraZeneca where she leads an in vivo pharamacology team that delivers across the Oncology portfolio. Elizabeth plays a key role in driving the in vivo strategy, including introduction and characterisation of novel models. Elizabeth joined AstraZeneca in 2016 as team leader and has worked across a variety of oncology projects targeting both the tumour and the immune system. Prior to her time at AstraZeneca Elizabeth has worked at both Evotec and Novartis Institute for Biomedical Research. Elizabeth did her PhD and post doc in respiratory diseases at the National Heart and Lung Institute (NHLI) Imperial college.
